Celltrion | 068270 - Sales Revenues

Stock Price
220,000.00
Daily Change
2,500.00 1.15%
Monthly
4.27%
Yearly
22.49%
Q1 Forecast
202,377.00

Celltrion reported KRW1.03T in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 18.42M 14K Jun/2025
Celltrion KRW 1.03T 68.49B Sep/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Moderna USD 1.02B 878M Sep/2025
Organon & Co USD 1.6B 10M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 190M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025